The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
Phase of Trial: Phase IV
Latest Information Update: 24 May 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 03 Feb 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
- 03 Feb 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jan 2018 as reported by ClinicalTrials.gov record.